Company Comparison
Multiscale AI model for biology vs BioAnalytics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Multiscale AI model for biology | BioAnalytics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Boston |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $55M |
| Valuation | — | — |
What They Build
Multiscale AI model for biology
Develops AI models for analyzing biological systems across multiple scales, from molecular to organism levels.
BioAnalytics
Boston-based biotech company developing analytics and data solutions for the life sciences industry.
Key Investors
Multiscale AI model for biology
BioAnalytics
No investors listed.
Sector Overlap
Both Multiscale AI model for biology and BioAnalytics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.